Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria

The recently revised World Health Organization (WHO) classification of myeloid neoplasms recognizes prefibrotic myelofibrosis (prePMF) as a distinct entity, characterized by well-defined histopathologic features together with minor clinical criteria (leukocytes, anemia, increased LDH, splenomegaly)....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Rumi, Elisa, Boveri, Emanuela, Bellini, Marta, Pietra, Daniela, Ferretti, Virginia V., Sant’Antonio, Emanuela, Cavalloni, Chiara, Casetti, Ilaria C., Roncoroni, Elisa, Ciboddo, Michele, Benvenuti, Pietro, Landini, Benedetta, Fugazza, Elena, Troletti, Daniela, Astori, Cesare, Cazzola, Mario
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731910/
https://ncbi.nlm.nih.gov/pubmed/29254200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21594
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia